首页> 外文期刊>World Allergy Organization Journal >Beta-lactam allergy in Chinese patients and factors predicting genuine allergy
【24h】

Beta-lactam allergy in Chinese patients and factors predicting genuine allergy

机译:β-内酰胺过敏中国患者和预测真正过敏的因素

获取原文
           

摘要

Introduction Beta-lactams (BL) are the most frequently reported drug allergy, but the vast majority of patients are found not to be genuinely allergic after evaluation. Few studies have investigated the clinical predictors of genuine BL allergy, and the prevalence in hospitalized Chinese patients is unknown. Methods Patients admitted to a tertiary hospital in Hong Kong (HK) were analyzed to identify the prevalence and factors associated with the presence of BL allergy labels among hospitalized Chinese patients. A combined cohort of patients having completed allergy investigation for suspected BL allergies in the United Kingdom (UK) and HK were analyzed to identify predictors of genuine allergy. Results The prevalence of BL allergy labels in hospitalized HK Chinese was 5%, which was associated with female gender and concomitant non-BL antibiotic allergy labels. The rate of genuine BL allergy patients referred for suspected allergies in the UK and HK cohort was only 14%. History of anaphylaxis and interval of less than a year since the index reaction were independent clinical predictors of genuine BL allergy. The negative predictive value of penicillin skin testing was 90%, confirming the need for drug provocation testing after negative skin testing. There was a high rate of confirmed piperacillin-tazobactam allergy. Discussion The estimated true prevalence of genuine BL allergy in hospitalized HK Chinese is around 0.5%. This?high rate of BL mislabeling highlights the need for comprehensive allergy evaluation and screening. History of anaphylaxis and duration since the index reaction are important predictors of genuine allergy. Piperacillin-tazobactam allergy may pose a unique challenge in this population with a high prevalence of suspected allergies, surging antibiotic resistance, and lack of testing available.
机译:引言β-内酰胺(BL)是最常见的药物过敏,但绝大多数患者被发现在评估后不太过敏。少数研究研究了真正的BL过敏的临床预测因子,住院治疗中国病人的患病率未知。方法分析了香港(香港)在香港第三节医院患者的患者,以确定与住院治疗的中国患者BL过敏标签有关的患病率和因素。分析了在联合王国(英国)和香港有疑似BL过敏的疑似BL过敏症的过敏调查的组合群组,以确定真正过敏的预测因素。结果住院HK中文BL过敏标签的患病率为5%,与女性性别和伴随的非BL抗生素过敏标签有关。在英国和香港队列队列中称为怀疑过敏的真正BL过敏患者的速率仅为14%。由于指数反应是正品Bl过敏的临床预测因子,但由于指数反应的独立临床预测因子,过敏反应的历史和少于一年。青霉素皮肤检测的负面预测值为90%,确认负皮肤检测后对药物挑衅检测的需要。有很高的确认的哌啶蛋白 - 塔唑米过敏。讨论住院HK中文真正BL过敏的估计真正患病率约为0.5%。这是大速率的BL MISLABELING突出了综合过敏评估和筛选的需求。过敏反应和持续时间的历史,因为指数反应是真正过敏的重要预测因子。 Piperacillin-Tazobactam过敏可能在这种人群中对令人疑似过敏,抗生素抗性和缺乏进行测试的患病率很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号